Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Cantor Fitzgerald
Covington
Boehringer Ingelheim
Accenture
Julphar
Farmers Insurance
Fish and Richardson
Fuji

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020210

« Back to Dashboard

NDA 020210 describes PROPULSID, which is a drug marketed by Janssen Pharms and Janssen Pharma and is included in three NDAs. Additional details are available on the PROPULSID profile page.

The generic ingredient in PROPULSID is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.
Summary for 020210
Tradename:PROPULSID
Applicant:Janssen Pharms
Ingredient:cisapride monohydrate
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020210

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Jul 29, 1993TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Dec 23, 1993TE:RLD:No

Expired US Patents for NDA 020210

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-001 Jul 29, 1993 ➤ Sign Up ➤ Sign Up
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-002 Dec 23, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
Cipla
McKinsey
Chubb
Farmers Insurance
Johnson and Johnson
Cerilliant
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot